Nubeqal (Darolutamide) 300mg Tablets with 120 Skip to content
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping to all of Mexico.
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping throughout Mexico

Nubeqal (Darolutamide) 300mg Tablets with 120

Sold out
Original price $ 117,076.92
Original price $ 117,076.92 - Original price $ 117,076.92
Original price $ 117,076.92
Current price $ 105,369.23
$ 105,369.23 - $ 105,369.23
Current price $ 105,369.23
SKU 10963
Availability:
Out of stock
Notify me when they have inventory available

¿Necesitas este producto u otro medicamento?

Este producto está agotado por el momento. Nuestros asesores farmacéuticos pueden ayudarte a conseguirlo o encontrar la mejor alternativa para tu tratamiento.

Contáctanos por WhatsApp

Category

Prescription medications

Line

Oncology

Brand

Nubeqal

Molecule

Darolutamide

Presentation

300 mg tablets, bottle with 120 tablets

Laboratory

Wecare Pharma

Indications

Nubeqal (Darolutamide) is indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer. This medication acts as an androgen receptor inhibitor, interfering with androgen signaling that can lead to tumor growth and progression. The efficacy of Darolutamide has been evaluated in clinical studies, where its ability to delay disease progression compared to standard treatment has been demonstrated. Its use is recommended under the supervision of a specialized oncology physician.

Composition

Each Nubeqal tablet contains 300 mg of Darolutamide as the active ingredient. It also contains excipients that facilitate the formulation and stability of the medication.

Contraindications

Nubeqal is contraindicated in patients with known hypersensitivity to Darolutamide or any of the excipients in the formulation. It is also contraindicated in women and children, as safety and efficacy have not been established in these populations. Its use in combination with certain other treatments should be evaluated by a physician due to potential interactions.

Precautions

Before starting treatment with Nubeqal, a complete medical evaluation is important. The patient's pre-existing medical conditions, as well as other treatments they are receiving, should be considered. Regular follow-up during treatment is recommended to evaluate the therapeutic response and the appearance of adverse effects. In case of unusual symptoms, a doctor should be consulted immediately.

Storage

Store Nubeqal in its original packaging, at room temperature, protected from light and humidity. Keep out of reach of children. Do not use after the expiration date indicated on the package.

Prescription required.

Consult your doctor.

Shipping

  1. Free home delivery by local branches on orders over $1000. Otherwise, a $50 fee will be added in the cities of Querétaro and La Paz, BCS, and $150 in San José del Cabo and Cabo San Lucas, BCS.
  2. FREE national shipping via ground on orders over $1,500.00. Otherwise, a fee of $170.00 MXN (One hundred seventy Mexican pesos) will be added for a standard package with dimensions up to 20cm x 20cm x 20cm and 1kg in weight, and $290.00 MXN (Two hundred ninety Mexican pesos) for packages exceeding the aforementioned dimensions or weight.
  3. In case of oversized items, the corresponding fee will apply according to the parcel service.
  4. Orders received after 2:00 PM will be shipped the next day.
  5. For more details, please consult our shipping policy.

Payment and Security

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Category

Prescription medications

Line

Oncology

Brand

Nubeqal

Molecule

Darolutamide

Presentation

300 mg tablets, bottle with 120 tablets

Laboratory

Wecare Pharma

Indications

Nubeqal (Darolutamide) is indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer. This medication acts as an androgen receptor inhibitor, interfering with androgen signaling that can lead to tumor growth and progression. The efficacy of Darolutamide has been evaluated in clinical studies, where its ability to delay disease progression compared to standard treatment has been demonstrated. Its use is recommended under the supervision of a specialized oncology physician.

Composition

Each Nubeqal tablet contains 300 mg of Darolutamide as the active ingredient. It also contains excipients that facilitate the formulation and stability of the medication.

Contraindications

Nubeqal is contraindicated in patients with known hypersensitivity to Darolutamide or any of the excipients in the formulation. It is also contraindicated in women and children, as safety and efficacy have not been established in these populations. Its use in combination with certain other treatments should be evaluated by a physician due to potential interactions.

Precautions

Before starting treatment with Nubeqal, a complete medical evaluation is important. The patient's pre-existing medical conditions, as well as other treatments they are receiving, should be considered. Regular follow-up during treatment is recommended to evaluate the therapeutic response and the appearance of adverse effects. In case of unusual symptoms, a doctor should be consulted immediately.

Storage

Store Nubeqal in its original packaging, at room temperature, protected from light and humidity. Keep out of reach of children. Do not use after the expiration date indicated on the package.

Prescription required.

Consult your doctor.